NasdaqGM:YI

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

111, Inc., through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. More Details


Snowflake Analysis

Adequate balance sheet with limited growth.


Similar Companies

Share Price & News

How has 111's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: YI has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-3.5%

YI

-3.0%

US Consumer Retailing

-4.6%

US Market


1 Year Return

46.1%

YI

13.6%

US Consumer Retailing

11.5%

US Market

Return vs Industry: YI exceeded the US Consumer Retailing industry which returned 13.6% over the past year.

Return vs Market: YI exceeded the US Market which returned 11.5% over the past year.


Shareholder returns

YIIndustryMarket
7 Day-3.5%-3.0%-4.6%
30 Day10.7%1.9%-0.9%
90 Day5.3%6.6%2.2%
1 Year46.1%46.1%15.4%13.6%14.0%11.5%
3 Yearn/a58.2%49.4%34.5%25.6%
5 Yearn/a91.0%71.7%73.0%53.6%

Price Volatility Vs. Market

How volatile is 111's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is 111 undervalued compared to its fair value and its price relative to the market?

6.34x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: YI ($6.81) is trading above our estimate of fair value ($2.37)

Significantly Below Fair Value: YI is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: YI is unprofitable, so we can't compare its PE Ratio to the US Consumer Retailing industry average.

PE vs Market: YI is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate YI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: YI is overvalued based on its PB Ratio (6.3x) compared to the US Consumer Retailing industry average (1.5x).


Next Steps

Future Growth

How is 111 forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

136.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: YI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: YI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: YI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: YI's revenue (52.6% per year) is forecast to grow faster than the US market (10% per year).

High Growth Revenue: YI's revenue (52.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if YI's Return on Equity is forecast to be high in 3 years time


Next Steps

  • Explore growth companies in the Consumer Retailing industry.

Past Performance

How has 111 performed over the past 5 years?

-18.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: YI is currently unprofitable.

Growing Profit Margin: YI is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: YI is unprofitable, and losses have increased over the past 5 years at a rate of 18% per year.

Accelerating Growth: Unable to compare YI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: YI is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (52.6%).


Return on Equity

High ROE: YI has a negative Return on Equity (-84.7%), as it is currently unprofitable.


Next Steps

Financial Health

How is 111's financial position?


Financial Position Analysis

Short Term Liabilities: YI's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥1.2B).

Long Term Liabilities: YI's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥59.4M).


Debt to Equity History and Analysis

Debt Level: YI's debt to equity ratio (20.1%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if YI's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: YI has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if YI has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is 111 current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate YI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate YI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if YI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if YI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of YI's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.9yrs

Average management tenure


CEO

Junling Liu (55 yo)

5.75yrs

Tenure

Mr. Junling Liu is Co-founder of 111, Inc. and has been its Chairman and Chief Executive Officer since 2015. Mr. Liu has been Co-Chairman of 111, Inc. since September 2018. He serves as Strategic Advisor a ...


Leadership Team

NamePositionTenureCompensationOwnership
Gang Yu
Co-Founder & Executive Chairman5.75yrsno data21.86%
CN¥ 122.6m
Junling Liu
Co-Founder5.75yrsno data22.5%
CN¥ 126.2m
Yang Chen
Chief Financial Officer1.58yrsno datano data
Haihui Wang
Co-Chief Operating Officer1.92yrsno datano data
Pengcheng Zhu
Co-Chief Operating Officer1.92yrsno datano data
Monica Mu
IR Directorno datano datano data
Anfeng Guo
Chief Innovation Officer0.42yrno datano data
Alex Liu
Finance Directorno datano datano data

1.9yrs

Average Tenure

55yo

Average Age

Experienced Management: YI's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Gang Yu
Co-Founder & Executive Chairman5.75yrsno data21.86%
CN¥ 122.6m
Junling Liu
Co-Founder5.75yrsno data22.5%
CN¥ 126.2m
Jian Sun
Independent Director2.08yrsno datano data
Jun Luo
Independent Director2.08yrsno datano data
Leon Lian Chen
Director1.42yrsno datano data
Nee Chuan Teo
Independent Director2.08yrsno datano data

2.1yrs

Average Tenure

55yo

Average Age

Experienced Board: YI's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

111, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: 111, Inc.
  • Ticker: YI
  • Exchange: NasdaqGM
  • Founded: 2010
  • Industry: Drug Retail
  • Sector: Consumer Retailing
  • Market Cap: US$560.867m
  • Shares outstanding: 82.36m
  • Website: https://www.111.com.cn

Number of Employees


Location

  • 111, Inc.
  • No. 295 ZuChongZhi Road
  • 3-5 Floors
  • Shanghai
  • 201203
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
YINasdaqGM (Nasdaq Global Market)YesADSUSUSDSep 2018

Biography

111, Inc., through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The compan ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/29 00:50
End of Day Share Price2020/10/28 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.